BrandonGeorgeSmagloMDFACP

PubMed

• 2 citations
  Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial.
  Ethan B Ludmir, Alexander D Sherry, Bryan M Fellman, Suyu Liu, Tharakeswara Bathala
  Journal of Clinical Oncology. 2024-11-10
• Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series.
  Ashwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, Kristin D Alfaro-Munoz, Brandon G Smaglo
  Cancers. 2024-10-09
• Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma.
  Mahmoud Yousef, Mark W Hurd, Abdelrahman Yousef, Ethan B Ludmir, Ashwathy B Pillai
  The Oncologist. 2024-07-16

Lectures

• Targeting pancreatic cancer using nonengineered, multiantigen specific T cells (TACTOPS) 
  AACR Immune Cell Therapies for Cancer meeting, San Francisco, CA - 7/20/2019
• Neoadjuvant Chemotherapy Alone Versus Neoadjuvant Chemoradiation Therapy for Locally Advanced Esophageal Cancer -AND- Who Benefits from Adjuvant Therapy following Neoa... 
  Current Medical and Surgical Management of Esophageal Diseases Meeting
• State-of-the-Art Medical Management of Colorectal Cancer 
  Baylor St Luke’s Medical Center Oncology Grand Rounds, - 3/20/2017
• Is there an optimal treatment sequence in the palliative management of mCRC? 
  The 12th Annual Meeting of the International Society of Gastrointestinal Oncology, - 10/2015
• Targeted Therapy for Resectable GIST 
  Medstar Georgetown University Hospital Second Annual Symposium on GIST - 9/12/2015
• Systemic Therapy for Gastric Cancer 
  The 11thAnnual Georgetown Meeting on GastroIntestinal Endoscopy, Foregut & Pancreatobiliary Surgery - 3/7/2015
• Adjuvant Therapy for Resectable GIST 
  Medstar Georgetown University Hospital First Annual Symposium on GIST - 5/10/2014
• Join now to see all